Francesco Cognetti
Francesco Cognetti
Direttore Oncologia Medica 1 IFO Istituto Nazionale Tumori Regina Elena Roma
Verified email at ifo.it
TitleCited byYear
Nivolumab in previously untreated melanoma without BRAF mutation
C Robert, GV Long, B Brady, C Dutriaux, M Maio, L Mortier, JC Hassel, ...
New England journal of medicine 372 (4), 320-330, 2015
27662015
Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer
J Bernier, C Domenge, M Ozsahin, K Matuszewska, JL Lefèbvre, ...
New England Journal of Medicine 350 (19), 1945-1952, 2004
21512004
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
BJ Solomon, T Mok, DW Kim, YL Wu, K Nakagawa, T Mekhail, E Felip, ...
New England Journal of Medicine 371 (23), 2167-2177, 2014
16382014
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2–positive metastatic breast …
M Marty, F Cognetti, D Maraninchi, R Snyder, L Mauriac, M Tubiana-Hulin, ...
Journal of clinical oncology 23 (19), 4265-4274, 2005
16032005
Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non–small-cell lung cancer
GV Scagliotti, R Fossati, V Torri, L Crino, G Giaccone, G Silvano, ...
Journal of the National Cancer Institute 95 (19), 1453-1461, 2003
7052003
European Organization for Research and Treatment of Cancer Trial 22931. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer
J Bernier
N Engl J Med 350, 1956-1952, 2004
452*2004
Cancer in the elderly: why so badly treated?
IS Fentiman, U Tirelli, S Monfardini, M Schneider, J Festen, F Cognetti, ...
The Lancet 335 (8696), 1020-1022, 1990
3831990
Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
L Serrone, M Zeuli, FM Sega, F Cognetti
Journal of experimental & clinical cancer research: CR 19 (1), 21-34, 2000
3572000
Antiangiogenic potential of the mammalian target of rapamycin inhibitor temsirolimus
D Del Bufalo, L Ciuffreda, D Trisciuoglio, M Desideri, F Cognetti, G Zupi, ...
Cancer research 66 (11), 5549-5554, 2006
3342006
Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy
A Pace, A Savarese, M Picardo, V Maresca, U Pacetti, G Del Monte, ...
Journal of Clinical Oncology 21 (5), 927-931, 2003
3242003
Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone.
F Roila, M Tonato, F Cognetti, E Cortesi, G Favalli, M Marangolo, ...
Journal of Clinical Oncology 9 (4), 675-678, 1991
3221991
Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic …
M Clavel, JB Vermorken, F Cognetti, P Cappelaere, PHM Mulder, ...
Annals of Oncology 5 (6), 521-526, 1994
2741994
A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis
A Alimonti, C Nardella, Z Chen, JG Clohessy, A Carracedo, LC Trotman, ...
The Journal of clinical investigation 120 (3), 681-693, 2010
2702010
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with …
H Roché, L Yelle, F Cognetti, L Mauriac, C Bunnell, J Sparano, P Kerbrat, ...
Journal of clinical oncology 25 (23), 3415-3420, 2007
2402007
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised …
E Pujade-Lauraine, JA Ledermann, F Selle, V Gebski, RT Penson, ...
The Lancet Oncology 18 (9), 1274-1284, 2017
2042017
Benefit of taxanes as adjuvant chemotherapy for early breast cancer: pooled analysis of 15,500 patients
E Bria, C Nistico, F Cuppone, P Carlini, M Ciccarese, M Milella, G Natoli, ...
Cancer 106 (11), 2337-2344, 2006
1772006
Zoledronic-acid-induced circulating level modifications of angiogenic factors, metalloproteinases and proinflammatory cytokines in metastatic breast cancer patients
G Ferretti, A Fabi, P Carlini, P Papaldo, PC Fei, S Di Cosimo, N Salesi, ...
Oncology 69 (1), 35-43, 2005
1712005
Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial
A Pace, D Giannarelli, E Galie, A Savarese, S Carpano, M Della Giulia, ...
Neurology 74 (9), 762-766, 2010
1692010
Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian …
F Cognetti, EM Ruggeri, A Felici, M Gallucci, G Muto, CF Pollera, ...
Annals of oncology 23 (3), 695-700, 2011
1542011
Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials
E Bria, F Cuppone, M Fornier, C Nisticò, P Carlini, M Milella, I Sperduti, ...
Breast cancer research and treatment 109 (2), 231-239, 2008
1462008
The system can't perform the operation now. Try again later.
Articles 1–20